DIAGNOS Announces AGM Date
DIAGNOS Announces AGM Date
DIAGNOS initiates a clinical trial study in the USA commencing December 6th 2021
DIAGNOS initiates a clinical trial study in the USA commencing December 6th 2021
DIAGNOS lancera une étude d’essai clinique aux États-Unis à partir du 6 décembre 2021
DIAGNOS lancera une étude d’essai clinique aux éЙtats Unis à partir du 6 décembre 2021
DIAGNOS Annouces Stock Options Grants
DIAGNOS Annouces Stock Options Grants
DIAGNOS Announces contract with the third largest optical chain store in Costa Rica
DIAGNOS Announces contract with the third largest optical chain store in Costa Rica
DIAGNOS annonce lexercice de bons de souscription et une mise a jour sur son encaisse
DIAGNOS annonce lexercice de bons de souscription et une mise a jour sur son encaisse
Diagnos ADK uses AI and Telemedicine to Scan your Eye for Health Issues in 16 Countries 1
Diagnos ADK uses AI and Telemedicine to Scan your Eye for Health Issues in 16 Countries 1
Echelon Capital Markets DIAGNOS Inc. Initiating Coverage – Keep Your Eye on This AI Company Taking on the Leading Cause of Blindness 1
Echelon Capital Markets DIAGNOS Inc. Initiating Coverage У Keep Your Eye on This AI Company Taking on the Leading Cause of Blindness 1
DIAGNOS annonce la finalisation sa nouvelle application CARA STROKE
DIAGNOS annonce la finalisation sa nouvelle application CARA STROKE
Echelon Capital Markets DIAGNOS Inc. Initiating Coverage – Keep Your Eye on This AI Company Taking on the Leading Cause of Blindness
Echelon Capital Markets DIAGNOS Inc. Initiating Coverage У Keep Your Eye on This AI Company Taking on the Leading Cause of Blindness
